The project is focused on developing a solution that leverages artificial intelligence (AI) to detect and monitor brain aneurysms on scans faster and more efficiently, and has already received a Cooperative Research Centres Projects (CRC-P) grant of $2.1m from the Department of Industry, Innovation and Science.
Fujitsu will lead the initiative and leverage its AI and digital solutions capability through its dedicated innovation team in Australia – and GE Healthcare will contribute through its leading medical imaging technology.
In addition, Macquarie University and Macquarie Medical Imaging will provide clinical expertise for the development and testing of the technology, with the project initially focused on refining the technology with a view to creating a fully commercialised solution that will be distributed initially through radiology practices in Australia and eventually on a worldwide basis.
“AI in particular has the capability to make our daily lives more comfortable and contribute to solving difficult problems such as detecting serious medical issues early and allowing more timely treatment intervention. This is an excellent demonstration of Fujitsu’s commitment to creating human-centric innovation together with our customers and partners to build a trusted future where everyone can feel safe.”
“As the consequences of brain aneurysm rupture are often fatal, effective and expedient detection is crucial. Unfortunately screening and monitoring takes time and specialist expertise not afforded by every radiology practice,” said Matt Tucker, President and CEO GE Healthcare Australia & New Zealand.
“The application of AI can give doctors better insights more quickly and produce fewer variable results. We are proud to be part of this program that will transform brain aneurysm diagnosis and improve patient outcomes.”
Professor Patrick McNeil, Deputy Vice Chancellor Medicine and Health and Executive Dean, Faculty of Medicine and Health Sciences, Macquarie University, said, “This is an excellent example of the MQ Health model of “Heal, Learn and Discover” in action with industry”.
“Macquarie University, with its own hospital and clinical expertise is well placed to actively contribute to the development of applied medical innovations and welcomes the opportunity to work with leading information technology, healthcare and diagnostic companies such as Fujitsu, GE Healthcare and Macquarie Medical Imaging.”
“This is an amazing opportunity to be able to address the problem of the rapid and accurate diagnosis of brain aneurysms. Even in ideal circumstances, detecting brain aneurysms is time and expertise intensive and missed aneurysms can have terrible outcomes,” said Professor John Magnussen, Diagnostic and Interventional Radiologist at Macquarie Medical Imaging.
“By creating an AI assistant to automatically flag potential aneurysms and allow for accurate follow-up, we can make a huge difference to patient care."